Lisa Lorraine Howard Shwartz, NP
Nurse Practitioner · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 14
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
14 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Lisa Lorraine Howard Shwartz’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Drugs they prescribed that Part D paid
$4,008
Pharmacies billed $4,008 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 104) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
103 generic and fewer than 11 brand-name prescriptions · $4,008 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trazodone | 13 | $461 | $35 |
| Atomoxetine | 13 | $185 | $14 |
| Escitalopram | 12 | $102 | $9 |
Year by year
| 2024 | 104 | None | 0% (0) | None | $4,008 |
| 2023 | 149 | 12 | 0% (0) | 8% | $57,442 |
| 2022 | 259 | 11 | 0% (0) | 9% | $42,333 |
| 2021 | 143 | 24 | 0% (0) | 8% | $8,005 |
| 2020 | 371 | 59 | 0% (0) | 13% | $57,188 |
| 2019 | 74 | 14 | 0% (0) | 20% | $18,664 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Gabapentin | 15 | $638 | $43 |
| Venlafaxine Hcl Er | 11 | $424 | $39 |
| Quetiapine | 16 | $371 | $23 |
| Zolpidem | 12 | $20 | $2 |
2022: 9 drugs
| Venlafaxine Hcl Er | 21 | $509 | $24 |
| Quetiapine | 26 | $388 | $15 |
| Clonazepam | 19 | $313 | $16 |
| Pregabalin | 17 | $266 | $16 |
| Sertraline | 13 | $206 | $16 |
| Alprazolam | 20 | $149 | $7 |
| Gabapentin | 15 | $136 | $9 |
| Trazodone | 13 | $102 | $8 |
| Zolpidem | 13 | $17 | $1 |
2021: 5 drugs
| Duloxetine | 12 | $296 | $25 |
| Gabapentin | 15 | $174 | $12 |
| Quetiapine | 14 | $135 | $10 |
| Sertraline | 19 | $114 | $6 |
| Trazodone | 15 | $97 | $6 |
2020: 13 drugs
| Trintellix | 21 | $8,840 | $421 |
| Haloperidol Decanoate | 20 | $914 | $46 |
| Olanzapine | 45 | $843 | $19 |
| Divalproex | 12 | $573 | $48 |
| Mirtazapine | 12 | $329 | $27 |
| Sertraline | 39 | $271 | $7 |
| Risperidone | 21 | $209 | $10 |
| Trazodone | 18 | $206 | $11 |
| Bupropion Xl | 12 | $206 | $17 |
| Lithium Carbonate | 16 | $198 | $12 |
| Duloxetine | 12 | $180 | $15 |
| Lamotrigine | 11 | $154 | $14 |
| Venlafaxine Hcl Er | 12 | $124 | $10 |
2019: 1 drug
| Olanzapine | 11 | $175 | $16 |
Money from drug and device companies
$293 in 2025
| 2025 | 7 | 13 | None | $293 |
| 2024 | 5 | 8 | None | $322 |
| 2023 | 8 | 28 | None | $671 |
| 2022 | 10 | 49 | None | $1,044 |
| 2021 | 9 | 36 | None | $873 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lundbeck | Rexulti | $69 | 3 payments
|
| Abbvie | Vraylar | $58 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $57 | 2 payments
|
| Vanda Pharmaceuticals | Fanapt | $37 | 1 payment
|
| Bausch Health US | Aplenzin | $24 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $24 | 1 payment
|
See all 13 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-08 | Caplyta | $25 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-06 | Trintellix | $24 |
| Lundbeck | Meals · 2025-10-03 | Rexulti | $28 |
| Abbvie | Meals · 2025-09-22 | Vraylar | $16 |
| Bausch Health US | Meals · 2025-08-19 | Aplenzin | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-08-07 | Abilify Asimtufii | $24 |
| Lundbeck | Meals · 2025-05-09 | Rexulti | $25 |
| Abbvie | Meals · 2025-05-05 | Vraylar | $14 |
| Abbvie | Meals · 2025-04-25 | Vraylar | $14 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-07 | Caplyta | $32 |
| Vanda Pharmaceuticals | Meals · 2025-02-07 | Fanapt | $37 |
| Abbvie | Meals · 2025-01-27 | Vraylar | $14 |
| Lundbeck | Meals · 2025-01-10 | Rexulti | $16 |
See earlier years (2024, 2023, 2022, 2021)
2024: $322
| Axsome Therapeutics | Auvelity | $149 | 1 payment
|
| Lundbeck | Rexulti | $68 | 3 payments
|
| Abbvie | Vraylar | $60 | 2 payments
|
| Bausch Health US | Aplenzin | $23 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $21 | 1 payment
|
2023: $671
| Abbvie | Vraylar | $239 | 12 payments
|
| Otsuka America Pharmaceutical | Rexulti | $160 | 4 payments
|
| Vanda Pharmaceuticals | Fanapt | $72 | 3 payments
|
| Alkermes | Aristada | $63 | 3 payments
|
| Iti | Caplyta | $56 | 2 payments
|
| Bausch Health US | Aplenzin | $41 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $21 | 1 payment
|
| Lundbeck | Rexulti | $19 | 1 payment
|
2022: $1,044
| Abbvie | Vraylar | $350 | 19 payments
|
| Alkermes | Lybalvi | $223 | 9 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $101 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $73 | 3 payments
|
| Bausch Health US | Aplenzin | $66 | 4 payments
|
| Iti | Caplyta | $59 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $56 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $50 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $41 | 2 payments
|
| Lundbeck | Abilify Maintena | $27 | 1 payment
|
2021: $873
| AbbVie | Vraylar | $417 | 15 payments
|
| Iti | Caplyta | $140 | 5 payments
|
| Lundbeck | Brintellix | $105 | 5 payments
|
| Otsuka America Pharmaceutical | Rexulti | $59 | 3 payments
|
| Eisai | Dayvigo | $38 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $34 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $33 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $25 | 1 payment
|
| Jazz Pharmaceuticals | Sunosi | $21 | 1 payment
|
Professional record
- NPI
- 1760960785
- Licence
- CA 95012715
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2018-08-01
- NPI last updated
- 2019-12-23
- NPI record certified
- 2019-12-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3800 Coolidge Ave, Oakland, CA, 94602